Supplementary protection certificate for medicinal products

10-04-2019

On 13 February 2019, Parliament and Council negotiators agreed on amending the EU rules on patent protection for generic and biosimilar medicines. Parliament is due to vote on the compromise text, approved by its Committee on Legal Affairs (JURI), at its second plenary session in April.

On 13 February 2019, Parliament and Council negotiators agreed on amending the EU rules on patent protection for generic and biosimilar medicines. Parliament is due to vote on the compromise text, approved by its Committee on Legal Affairs (JURI), at its second plenary session in April.